Cours Escalon Medical Corp. Other OTC
Actions
ESMC
US2960743050
Equipement et technologie médicale avancés
CA 2022 | 10,7 M 9,65 M | CA 2023 | 12,18 M 10,98 M | Capitalisation | 1,85 M 1,67 M |
---|---|---|---|---|---|
Résultat net 2022 | - 0 | Résultat net 2023 | - 0 | VE / CA 2022 | 0,14 x |
Dette nette 2022 | 611 k 551 k | Dette nette 2023 | 205 184,81 | VE / CA 2023 | 0,15 x |
PER 2022 |
-28
x | PER 2023 |
8,37
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 98,1% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Richard DePiano
CEO | Chief Executive Officer | 58 | 01/11/00 |
Mark Wallace
DFI | Director of Finance/CFO | 55 | 01/01/97 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Lisa Napolitano
BRD | Director/Board Member | 61 | 01/01/03 |
Richard DePiano
CEO | Chief Executive Officer | 58 | 01/11/00 |
David Jacovini
BRD | Director/Board Member | 48 | 13/02/18 |
Varia. 1 janv. | Capi. | |
---|---|---|
+12,85% | 227 Md | |
+13,88% | 192 Md | |
+18,39% | 136 Md | |
+28,78% | 108 Md | |
+1,67% | 64,07 Md | |
+18,24% | 52,1 Md | |
+7,04% | 51,87 Md | |
+10,83% | 44,33 Md | |
+5,94% | 36,75 Md |